Annual General Meeting – Immunovia AB

On 6th May 2021, the Annual General Meeting (AGM) was held in Immunovia AB (publ), 556730-4299. Due…

Marker Therapeutics to Host First Quarter 2021 Operating and Financial Results Conference Call and Webcast on Wednesday, May 12, 2021

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies…